Panelists recently convened to discuss the impact of oral therapies on patients suffering from psoriasis, particularly in high-impact areas such as the scalp. These...
Clinical advancements in psoriasis treatment are underway with the introduction of second-generation phosphodiesterase 4 (PDE4) inhibitors, notably orismilast. This new oral medication aims to...